|
Hoji Alimi
Akihisa Akao
Gregg Alton
Jay Birnbaum
Edward Brown
Robert Burlingame
Richard Conley
Greg French
Jim Schutz
|
Hoji Alimi
Hojabr Alimi, one of our founders, has served as our chief executive officer, president and director since 1999 and was appointed as chairman of the board of directors in June 2006. Prior to co-founding our company with his spouse in 1999, Mr. Alimi was a corporate microbiologist for Arterial Vascular Engineering. Mr. Alimi received a B.A. in biology from Sonoma State University.
Akihisa Akao
Akihisa Akao has served as a director since 1999 and as a consultant since October 2005. Mr. Akao has served as president for White Moon Medical, Inc., a consulting company that provides advice to early-stage companies seeking to enter the Japanese medical products market. He served as the general manager in Japan at PowerMedical Interventions Inc., a medical device company, from January 2001 to September 2005. He also served as president of E-Med Japan, an application service provider for medical professionals and consumers, from 1999 to July 2000. Mr. Akao received a B.A. in electronic engineering from Doshisha University, Kyoto, Japan.
Gregg Alton
Gregg Alton has served as a director since January 2008. Mr. Alton is currently a senior vice president, general counsel and secretary at Gilead Sciences, Inc. His expertise lies in the areas legal affairs, public affairs, government affairs, and international access operations of publicly traded biopharmaceutical company. In addition, Mr. Alton is a member and chairman of Gilead Healthcare PAC, and a member of the board of Gilead Foundation. Since joining Gilead Sciences Inc. as associate general counsel in 1999, Mr. Alton has managed the company's departments of U.S. and European legal affairs; intellectual property; public affairs; international access operations; government affairs; and global government affairs. Previously, Mr. Alton was a corporate associate at the mergers and acquisitions group Cooley Godward LLP, where he counseled technology and biotechnology clients in transaction structures and related documentation. Prior to that, Mr. Alton served a similar role as a corporate associate at Mintz, Levin, Cohn, Ferris, Glovsky & Popeco. He received a BA in legal studies from the University of California at Berkeley, and a JD from Stanford Law School.
Jay Birnbaum
Jay Birnbaum has served as a director since April 2007. Dr. Birnbaum is a pharmacologist and previous to his current role as a consultant to pharmaceutical companies, he served as vice president of global project management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company's dermatology portfolio. Dr. Birnbaum is a co-founder of Kythera Biopharmaceuticals, a company developing products in aesthetic and restorative dermatology, as well as a member of NanoBio Corporation's scientific advisory board. He received both an M.S. and Ph.D. in pharmacology from the University of Wisconsin and a B.S. in biology from Trinity College in Connecticut.
Edward Brown
Mr. Brown is a managing director at TPG Growth, where he is responsible for making private equity investments in a broad range of companies in the healthcare industry. Prior to joining TPG in 2007, Mr. Brown co-founded Healthcare Investment Partners, or HIP, a private equity fund focused exclusively on healthcare, and served as a managing director of HIP since its inception in June 2004. Before forming HIP, Mr. Brown had over 17 years of experience in healthcare investment banking, most recently as a managing director at Credit Suisse First Boston, where he led the firm's West Coast healthcare effort and was one of the senior partners responsible for the firm's global life sciences practice, from August 2000 to June 2004. Mr. Brown served on the board of directors of Angiotech Pharmaceuticals, Inc., Oculus Innovative Sciences, and Replidyne, Inc. Mr. Brown received a B.A. in English from Middlebury College and an M.B.A. from UCLA, and attended graduate school at Oxford University in English literature.
Robert Burlingame
Robert Burlingame has served as a director since November 2006. Mr. Burlingame is the chief executive officer and chairman of the board of Burlingame Industries, Inc., a manufacturer of automated equipment specializing in the concrete rooftile industry, which he founded in 1969. He has held various senior management positions at several rooftile companies, including California Tile and Lifetile Corporation. Mr. Burlingame received a B.S. in business from Michigan State University and was a pilot in the U.S. Navy.
Richard Conley
Richard Conley has served as a director since 1999, and served as our secretary from July 2002 to June 2006. Since April 2001, Mr. Conley has served as executive vice president and chief operating officer at Don Sebastiani & Sons International Wine Negociants, a branded wine marketing company. From 1994 to March 2001, he served as senior vice president and chief operating officer at Sebastiani Vineyards, a California wine producer, where he was originally hired as chief financial officer in 1994. Mr. Conley received a B.S. in finance and accounting from Western Carolina University and an M.B.A. from St. Mary's University.
Greg French
Gregory French has served as a director since 2000. Mr. French is owner and chairman of the board of G&C Enterprises LLC, a real estate and investment company, which he founded in 1999. He held various engineering and senior management positions at several medical device companies, including Advanced Cardiovascular Systems, Peripheral Systems Group and Arterial Vascular Engineering. Mr. French received a B.S.I.E. from the California State Polytechnic University, San Luis Obispo.
Jim Schutz
James Schutz has served as our vice president of corporate development and general counsel since August 2003, as a director since May 2004 and corporate secretary since June 2006. From August 2001 to August 2003, Mr. Schutz served as general counsel at Jomed (formerly EndoSonic Corp.), an international medical device company. From 1999 to July 2001, Mr. Schutz served as in-house counsel at Urban Media Communications Corporation, an Internet/telecom company based in Palo Alto, California. Mr. Schutz received a B.A. in economics from the University of California, San Diego and a J.D. from the University of San Francisco School of Law.
|